University of Louisville
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Louisville sits in the top decile of US sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count).
University of Louisville: 217 sponsored US clinical trials, 46 recruiting.
University of Louisville sponsors 217 registered US clinical trials on ClinicalTrials.gov, 46 of them currently recruiting, and 132 completed. 26 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 9 trials.
Top-decile sponsor footprint
University of Louisville ranks in the top decile of sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
217 total, page 1 of 5
Non-invasive Spinal Cord Stimulation and Blood Pressure Regulation After Spinal Cord Injury
NCT07504055
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
NCT07250958
MeDex: No Perioperative Dexamethasone in Brain Metastases
NCT07044557
Betadine vs Sterile Water for Periurethral Preparation
NCT07044726
Saline Versus Balanced Crystalloid in Traumatic Brain Injury
NCT06953674
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
NCT06883513
Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol
NCT06705491
Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty
NCT06617338
Spinal Cord Stimulation for Parkinson's Disease Rehabilitation
NCT06804642
Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Patients
NCT06511804
Reactions to Distress (RED) In Louisville, KY Study
NCT07016945
Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia
NCT06644261
Supporting Resilience Among Re-entered Seniors
NCT06276452
Innovations in Personalizing Treatment Study
NCT06208605
Vaginal Baclofen Suppositories in Chronic Pelvic Pain
NCT05968937
Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury
NCT06019949
Resistance Training in Type 1 Diabetes Mellitus
NCT05315037
Guided Bone Regeneration With and Without the Use of Intra-marrow Penetrations
NCT06353399
Encouraging a Plant Based Diet in an Underserved Urban Population
NCT06090409
PDA Occlusion Using NIRS
NCT06359522
Complex and Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX)
NCT05838248
Esophageal and Gastric Registry and Biorepository
NCT05180253
Facing Eating Disorder Fears for Anorexia Nervosa
NCT05596799
LGG Supplementation in Patients With AUD and ALD
NCT05178069
Comparison Using a VLS Using GlideRite Stylet Versus TCI Articulating Introducer in Predictive Difficult Intubation
NCT04866472
Spinal Cord Stimulation and Respiration After Injury
NCT05178056
Intermediate Visual Space Perception
NCT05419713
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
NCT04845217
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
NCT05144633
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
NCT04990921
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
NCT03953768
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
NCT04193709
Intramedullary Bone Grafting for Open Tibial Shaft Fractures
NCT03891888
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
NCT04208828
Transcutaneous Spinal Stimulation: Safety and Feasibility for Upper Limb Function in Children With Spinal Cord Injury
NCT04032990
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT03842943
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
NCT03484299
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
NCT03670524
Task-specific Epidural Stimulation Study
NCT03364660
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
NCT03080974
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
NCT02674100
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
NCT03876288
Adrenergic Cholinergic Enteric Measures/Mapping
NCT04013282
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
NCT01638676
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
NCT00682032
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
NCT00919217
Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
NCT04740294
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
NCT04554693
Transformation of Paralysis to Stepping
NCT04105114
Transcutaneous Spinal Stimulation: Safety and Feasibility for Trunk Control in Children With Spinal Cord Injury
NCT03975634
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 21 |
| Phase 3 | 3 |
| Phase 4 | 23 |
What is open in the University of Louisville pipeline
46 recruiting of 217 indexed (21% open); 132 completed (61%).
Phase mix: 26 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Spinal Cord Injuries (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Louisville: open-pipeline peers nationwide
Peers matched on 217 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 217 trials (± recruiting share)
- Florida State University · 219 trials · 21% recruiting
- Penn State University · 219 trials · 17% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Ohio State University · 21% recruiting · 552 trials
- Medical College of Wisconsin · 21% recruiting · 447 trials
- Nova Southeastern University · 21% recruiting · 71 trials
- Colorado State University · 21% recruiting · 94 trials
Related
What to do with this University of Louisville page
217 registered trials is a research-attention snapshot, not an endorsement of University of Louisville or any single study.
- 46 of University of Louisville's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injuries is the condition University of Louisville studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Louisville pipeline card: 217 registered trials from official public datasets.Report a data error.